Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Xetra  >  Merck KGaA    MRK   DE0006599905

MERCK KGAA

(MRK)
  Report
Delayed Quote. Delayed Xetra - 10/23 11:35:23 am
131.85 EUR   +3.05%
10/21MERCK KGAA : Morgan Stanley reaffirms its Neutral rating
MD
10/21MERCK KGAA : Bernstein reiterates its Neutral rating
MD
10/16Physiomics Wins Contracts With Existing Customers
DJ
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo Merck KGaA
Merck KGaA is one of the world's leading pharmaceutical and chemical groups. Net sales break down by family of products as follows:

- pharmaceutical products (41.6%): prescription drugs for the treatment of diabetes, cancer, multiple sclerosis, infertility, cardiovascular disease, central nervous system disorders, inflammatory disorders, etc.;

- solutions and products for scientific and biotechnological research (42.6%) ;

- performance materials (15.8%): pigments and additives, liquid crystals, specialty chemicals, carbon-based organic materials, etc.

Net sales are distributed geographically as follows: Germany (6.3%), Switzerland (1.3%), Europe (21.7%), China (14.1%), Asia/Pacific (20.6%), the United States (24.8%), North America (1.3%), Latin America (6.3%), Middle East and Africa (3.6%).

Number of employees : 57 036 people.
Sales per Business
20182019Delta
EUR (in Million)%EUR (in Million)%
Life Science6,18541.7%6,86442.5% +10.98%
Healthcare6,24642.1%6,71441.6% +7.49%
Performance Materials2,40616.2%2,57415.9% +6.98%
Sales per region
20182019Delta
EUR (in Million)%EUR (in Million)%
United States3,70425%4,10125.4% +10.72%
Europe3,21521.7%3,36920.9% +4.79%
Asia Pacific3,05920.6%3,25020.1% +6.24%
China1,65911.2%2,04812.7% +23.45%
Germany1,4079.5%1,4759.1% +4.83%
Latin America879.005.9%965.006% +9.78%
Switzerland390.002.6%389.002.4% -0.26%
Middle East and Africa357.002.4%373.002.3% +4.48%
North America167.001.1%182.001.1% +8.98%
Managers
NameAgeSinceTitle
Stefan Oschmann632016Chairman-Executive Board & CEO
Wolfgang Büchele612014Chairman-Supervisory Board
Marcus Kuhnert, Dr.512014Chief Financial Officer
Christian Raabe, Dr.-2019Independent Member-Supervisory Board
Edeltraud Glänzer642008Independent Member-Supervisory Board
Jürgen Glaser572012Independent Member-Supervisory Board
Helga Rübsamen-Schaeff, Dr.712014Independent Member-Supervisory Board
Gabriele Eismann, Dr.582014Independent Member-Supervisory Board
Dietmar Oeter, Dr.542014Independent Member-Supervisory Board
Alexander Putz532020Member-Supervisory Board
Equities
Vote QuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 129,242,252 129,242,252 100.0% 0 0.0% 29.7%
Stock B 1 305,535,626 0 0.0% 0 0.0%
Shareholders
NameEquities%
Massachusetts Financial Services Co. 6,342,586 4.91%
The Vanguard Group, Inc. 4,067,700 3.15%
Select Equity Group LP 4,018,061 3.11%
Amundi Asset Management SA (Investment Management) 3,860,546 2.99%
DWS Investment GmbH 3,663,514 2.83%
McKinley Capital Management LLC 3,348,185 2.59%
Templeton Global Advisors Ltd. 3,015,906 2.33%
Norges Bank Investment Management 2,855,795 2.21%
Schroder Investment Management Ltd. 1,642,392 1.27%
Deka Investment GmbH 1,633,667 1.26%
Holdings
NameEquities%Valuation
Progyny, Inc. (PGNY) 4,108,9654.78%120,926,840 USD
Precigen, Inc. (PGEN) 27,398,51915.9%95,894,817 USD
PT Merck Tbk (MERK) 388,194,92086.7%75,915,399 USD
Markets and indexes
-
- Prime Standard
- DAX 30 / STOXX Europe 600
Stock Exchange Codes
- Bloomberg Code :  MRK:GR
- Reuters Code :  MRCG.DE
- Datastream Code :  D:MRK
Company contact information
Merck KGaA
Frankfurter Strasse 250
DE-64293 Darmstadt, Hessen


Phone : +49 (0)6151 72 0
Fax : +49 (0)6151 72 2000
Internet : http://www.merck.de
Brand Portfolio
In partnership withAllbrands.markets
More brands of Merck KGaA